Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing SlCLE10 in tomatoes boosts root hair growth and drought tolerance.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

CLE14 peptide promotes root hair growth in Arabidopsis.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

HLD10 can include increased body hair and Mongolian spots.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Tislelizumab can cause cutaneous lupus erythematosus.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

Lef1 helps stem cells become hair cells by interacting with specific signaling pathways.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lupus can progress to a more serious form, so careful monitoring is crucial.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

If someone has scaly skin, muscle stiffness, and intellectual disability, doctors should consider Sjogren-Larsson Syndrome, but other conditions if more symptoms are present.